Infliximab therapy for moderately severe Crohn’s disease and ulcerative colitis: a retrospective comparison over 6 years

BACKGROUND: Infliximab has shown benefit in Crohn’s disease (CD) and ulcerative colitis (UC). OBJECTIVE: Evaluation of long-term outcome of therapy for both diseases. METHODS: We analyzed retrospectively patients treated at infusion centers from one institution. Demographic, laboratory parameters le...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Alzafiri, Raed, Holcroft, Christina A, Malolepszy, Paula, Cohen, Albert, Szilagyi, Andrew
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2011
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3108681/
https://ncbi.nlm.nih.gov/pubmed/21694867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S16168
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires